Optimization of the composition of a nasal medicine with interleukin-1 antagonist β
In the development of new effective and safe drugs an important place is occupied by the issue of ensuring the stability of the dosage form. In this case, a significant contribution to this problem is made directly by the nature of the active pharmaceutical ingredient. Based on our experimental stud...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | |
| Опубликовано: |
The State Expert Center of the Ministry of Health of Ukraine,
2021-02-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |